178 related articles for article (PubMed ID: 7721786)
1. Receptor for interleukin 13. Interaction with interleukin 4 by a mechanism that does not involve the common gamma chain shared by receptors for interleukins 2, 4, 7, 9, and 15.
Obiri NI; Debinski W; Leonard WJ; Puri RK
J Biol Chem; 1995 Apr; 270(15):8797-804. PubMed ID: 7721786
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-4 (IL-4) and IL-13 bind to a shared heterodimeric complex on endothelial cells mediating vascular cell adhesion molecule-1 induction in the absence of the common gamma chain.
Schnyder B; Lugli S; Feng N; Etter H; Lutz RA; Ryffel B; Sugamura K; Wunderli-Allenspach H; Moser R
Blood; 1996 May; 87(10):4286-95. PubMed ID: 8639787
[TBL] [Abstract][Full Text] [Related]
3. Diminished responses to IL-13 by human monocytes differentiated in vitro: role of the IL-13Ralpha1 chain and STAT6.
Hart PH; Bonder CS; Balogh J; Dickensheets HL; Vazquez N; Davies KV; Finlay-Jones JJ; Donnelly RP
Eur J Immunol; 1999 Jul; 29(7):2087-97. PubMed ID: 10427971
[TBL] [Abstract][Full Text] [Related]
4. The primary binding subunit of the human interleukin-4 receptor is also a component of the interleukin-13 receptor.
Zurawski SM; Chomarat P; Djossou O; Bidaud C; McKenzie AN; Miossec P; Banchereau J; Zurawski G
J Biol Chem; 1995 Jun; 270(23):13869-78. PubMed ID: 7775445
[TBL] [Abstract][Full Text] [Related]
5. The IL-2 receptor gamma c chain does not function as a subunit shared by the IL-4 and IL-13 receptors. Implication for the structure of the IL-4 receptor.
He YW; Malek TR
J Immunol; 1995 Jul; 155(1):9-12. PubMed ID: 7602126
[TBL] [Abstract][Full Text] [Related]
6. Expression and function of the gamma c subunit of the IL-2, IL-4, and IL-7 receptors. Distinct interaction of gamma c in the IL-4 receptor.
He YW; Adkins B; Furse RK; Malek TR
J Immunol; 1995 Feb; 154(4):1596-605. PubMed ID: 7530740
[TBL] [Abstract][Full Text] [Related]
7. Targeting of interleukin-13 receptor on human renal cell carcinoma cells by a recombinant chimeric protein composed of interleukin-13 and a truncated form of Pseudomonas exotoxin A (PE38QQR).
Puri RK; Leland P; Obiri NI; Husain SR; Kreitman RJ; Haas GP; Pastan I; Debinski W
Blood; 1996 May; 87(10):4333-9. PubMed ID: 8639793
[TBL] [Abstract][Full Text] [Related]
8. IL-4 receptor alpha is an important modulator of IL-4 and IL-13 receptor binding: implications for the development of therapeutic targets.
Andrews AL; Holloway JW; Holgate ST; Davies DE
J Immunol; 2006 Jun; 176(12):7456-61. PubMed ID: 16751391
[TBL] [Abstract][Full Text] [Related]
9. The IL-13 receptor structure differs on various cell types and may share more than one component with IL-4 receptor.
Obiri NI; Leland P; Murata T; Debinski W; Puri RK
J Immunol; 1997 Jan; 158(2):756-64. PubMed ID: 8992992
[TBL] [Abstract][Full Text] [Related]
10. Receptors for interleukin (IL)-4 do not associate with the common gamma chain, and IL-4 induces the phosphorylation of JAK2 tyrosine kinase in human colon carcinoma cells.
Murata T; Noguchi PD; Puri RK
J Biol Chem; 1995 Dec; 270(51):30829-36. PubMed ID: 8530527
[TBL] [Abstract][Full Text] [Related]
11. Cloning and characterization of a specific interleukin (IL)-13 binding protein structurally related to the IL-5 receptor alpha chain.
Caput D; Laurent P; Kaghad M; Lelias JM; Lefort S; Vita N; Ferrara P
J Biol Chem; 1996 Jul; 271(28):16921-6. PubMed ID: 8663118
[TBL] [Abstract][Full Text] [Related]
12. Kinetic analysis of high affinity forms of interleukin (IL)-13 receptors: suppression of IL-13 binding by IL-2 receptor gamma chain.
Kuznetsov VA; Puri RK
Biophys J; 1999 Jul; 77(1):154-72. PubMed ID: 10388747
[TBL] [Abstract][Full Text] [Related]
13. Structure of IL-13 receptor: analysis of subunit composition in cancer and immune cells.
Murata T; Obiri NI; Debinski W; Puri RK
Biochem Biophys Res Commun; 1997 Sep; 238(1):90-4. PubMed ID: 9299458
[TBL] [Abstract][Full Text] [Related]
14. Differential responses of human monocytes and macrophages to IL-4 and IL-13.
Hart PH; Bonder CS; Balogh J; Dickensheets HL; Donnelly RP; Finlay-Jones JJ
J Leukoc Biol; 1999 Oct; 66(4):575-8. PubMed ID: 10534111
[TBL] [Abstract][Full Text] [Related]
15. A novel 4-kb interleukin-13 receptor alpha mRNA expressed in human B, T, and endothelial cells encoding an alternate type-II interleukin-4/interleukin-13 receptor.
Gauchat JF; Schlagenhauf E; Feng NP; Moser R; Yamage M; Jeannin P; Alouani S; Elson G; Notarangelo LD; Wells T; Eugster HP; Bonnefoy JY
Eur J Immunol; 1997 Apr; 27(4):971-8. PubMed ID: 9130652
[TBL] [Abstract][Full Text] [Related]
16. Binding of interleukin-13 and interleukin-4 to the interleukin (IL)-4/IL-13 receptor of human synovial fibroblasts.
Lutz RA; Feng N; Moser R
J Recept Signal Transduct Res; 1999; 19(1-4):181-90. PubMed ID: 10071757
[TBL] [Abstract][Full Text] [Related]
17. Specific antagonism of type I IL-4 receptor with a mutated form of murine IL-4.
Schnare M; Blum H; Jüttner S; Röllinghoff M; Gessner A
J Immunol; 1998 Oct; 161(7):3484-92. PubMed ID: 9759868
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-4 and interleukin-13: their similarities and discrepancies.
Chomarat P; Banchereau J
Int Rev Immunol; 1998; 17(1-4):1-52. PubMed ID: 9914942
[TBL] [Abstract][Full Text] [Related]
19. Characterization of IL-4 and IL-13 signals dependent on the human IL-13 receptor alpha chain 1: redundancy of requirement of tyrosine residue for STAT3 activation.
Umeshita-Suyama R; Sugimoto R; Akaiwa M; Arima K; Yu B; Wada M; Kuwano M; Nakajima K; Hamasaki N; Izuhara K
Int Immunol; 2000 Nov; 12(11):1499-509. PubMed ID: 11058569
[TBL] [Abstract][Full Text] [Related]
20. Human melanoma cells release soluble and functional receptors.
Badr G; Sayed D
Egypt J Immunol; 2006; 13(2):23-31. PubMed ID: 18689268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
